Deletion of 14-3-3ε and CRK: A clinical syndrome with macrocephaly, developmental delay, and generalized epilepsy

Journal of Child Neurology

Volumn 26, Issue 2, 2011, Pages 223-227

  Tenney, Jeffrey R ^a   Hopkin, Robert J ^a   Schapiro, Mark B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

developmental; epilepsy; genetics; Miller Dieker syndrome

Indexed keywords

ADAPTOR PROTEIN; PROTEIN 14 3 3; PROTEIN 14 3 3 EPSILON; PROTEIN CRK; UNCLASSIFIED DRUG;

ARTICLE; BRAIN VENTRICLE DILATATION; CASE REPORT; CHILD; CHROMOSOME 17P; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; DEVELOPMENTAL DISORDER; ELECTROENCEPHALOGRAPHY; EPICANTHUS; EPILEPTIC DISCHARGE; FACE DYSMORPHIA; FEMALE; FRONTAL BOSSING; GENERALIZED EPILEPSY; HUMAN; HYPERTELORISM; LIP MALFORMATION; MACROCEPHALY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SHORT STATURE; WHITE MATTER;

14-3-3 PROTEINS; BRAIN; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; CYTOGENETICS; DEVELOPMENTAL DISABILITIES; ELECTROENCEPHALOGRAPHY; EPILEPSY, GENERALIZED; FEMALE; HUMANS; MACROCEPHALY; PROTO-ONCOGENE PROTEINS C-CRK; SYNDROME;

EID: 79551645319     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073810379638     Document Type: Article

References (11)

1. Kato M., Dobyns WB Lissencephaly and the molecular basis of neuronal migration. Hum Mol Genet. 2003 ; 12: R89 - R96.
2. Wynshaw-Boris A. Lissencephaly and LIS1: insights into the molecular mechanisms of neuronal migration and development. Clin Genet. 2007 ; 72: 296-304.
3. Cardoso C., Leventer RJ, Ward HL, et al. Refinement of a 400-kb critical region allows genotypic differentiation between isolated issencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3. Am J Hum Genet. 2003 ; 72: 918-930.
4. Toyo-oka K., Shionoya A., Gambello MJ, et al. 14-3-3ε is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat Genet. 2003 ; 34: 274-285.
5. Feller SM, Posern G., Voss J., et al. Physiological signals and oncogenesis mediated through CRK family adaptor proteins. J Cell Physiol. 1998 ; 177: 535-552.
6. Balikova I., Menten B., de Ravel T., et al. Subtelomeric imbalances in phenotypically normal individuals. Hum Mutat. 2007 ; 28: 958-967.
7. Van Buggenhout G., Melotte C., Dutta B., et al. Mild Wolf-Hirschhorn syndrome: micro-array CGH analysis of atypical 4p16.3 deletions enables refinement of the genotype-phenotype map. J Med Genet. 2004 ; 41: 691-698.
8. South ST, Hannes F., Fisch GS, et al. Pathogenic significance of deletions distal to the currently described Wolf-Hirschhorn syndrome critical regions on 4p16.3 Am J Med Genet C Semin Med Genet. 2008 ; 148C: 270-274.
9. Nagamani SC, Zhang F., Shchelochkov OA, et al. Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment. J Med Genet. 2009 ; 46: 825-833.
10. Schinzel A., Niedrist D. Chromosome imbalances associated with epilepsy. Am J Med Genet. 2001 ; 106: 119-124.
11. Singh R., Gardner RJ, Crossland KM, et al. Chromosome abnormalities and epilepsy: a review for clinicians and gene hunters. Epilepsia. 2002 ; 43: 127-140.